MedPath

Metformin Hydrochloride

Metformin Hydrochloride Tablets, USP

Approved
Approval ID

3814cfed-029f-4231-bba3-89b2b4e01392

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 13, 2023

Manufacturers
FDA

Legacy Pharmaceutical Packaging, LLC

DUNS: 143213275

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Metformin Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68645-300
Application NumberANDA077095
Product Classification
M
Marketing Category
C73584
G
Generic Name
Metformin Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateDecember 13, 2023
FDA Product Classification

INGREDIENTS (6)

METFORMIN HYDROCHLORIDEActive
Quantity: 1000 mg in 1 1
Code: 786Z46389E
Classification: ACTIB
POVIDONE K90Inactive
Code: RDH86HJV5Z
Classification: IACT
POLYETHYLENE GLYCOL 6000Inactive
Code: 30IQX730WE
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
HYPROMELLOSE 2910 (5 MPA.S)Inactive
Code: R75537T0T4
Classification: IACT
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQ
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Metformin Hydrochloride - FDA Drug Approval Details